Porzio Expands Reach in Puerto Rico with Addition of Francisco E. Colón-Ramírez as Of Counsel

Hire Offers Strong Litigation Counsel for Class Action, Appellate, and Insurance Coverage Matters 

Porzio, Bromberg & Newman P.C. (Porzio) is delighted to announce that Francisco E. Colón-Ramírez has joined Porzio, Bromberg & Newman (PR), LLC, as Of Counsel. This addition will expand the reach of the law firm and its Porzio Life Sciences subsidiary in Puerto Rico, and further solidify Porzio's ability to serve clients' litigation and business needs in the region.

Colón-Ramírez is a litigator focused on professional liability, premises liability, products and medical devices, aviation, medical malpractice, class actions, directors’ and officers’ liability, and insurance regulatory and coverage. Colón-Ramírez has tried over ten federal jury cases with successful results, and has successfully defended all appeals taken to the First Circuit Court of Appeals.

Colón-Ramírez is also highly regarded in Puerto Rico for his work related to COVID-19. In the early stages of the pandemic, Colón-Ramírez and others founded the Task Force Ciudadano, a team of volunteer citizens who track and report COVID-19 related information in Puerto Rico. Since then they have created a metrics-based system to rate the threat of the pandemic. The page has quickly become recognized as the go-to resource for businesses and citizens in Puerto Rico.

"Francisco's entrepreneurial spirit and extensive litigation experience are a perfect match for Porzio," said Vito A. Gagliardi, Jr., managing principal of Porzio and president of the firm's three subsidiaries, Porzio Life Sciences, LLC, Porzio Governmental Affairs, LLC, and Porzio Compliance Services, LLC. "We are thrilled to add Francisco to our team and to further our ability to provide extraordinary client service to current and prospective clients in Puerto Rico."

The announcement of Colón-Ramírez comes just fourteen months after Porzio first announced the firm's expansion to Puerto Rico with the addition of Luis G. Rivera-Marin.  Rivera-Marin is Of Counsel to the law firm and Manager, Puerto Rico Operations of Porzio Life Sciences, LLC. Rivera-Marin states, "Francisco adds gravitas to our presence in Puerto Rico, and together we will be strong advocates for the business, insurance and pharmaceutical communities on the island."

About Porzio, Bromberg & Newman, P.C.

At Porzio, Bromberg & Newman, P.C., a dynamic approach to problem-solving and client service creates the energy and passion that form the foundation of the firm. Porzio meets clients’ rapidly changing needs by realigning our considerable resources to address demanding matters. Porzio is a business-oriented multidisciplinary law practice where attorneys collaborate with each other and with clients to find solutions to challenges and problems. Porzio strives to incorporate diversity and inclusion in its daily practices to create an enriched workplace that benefits the firm’s clients. With more than 90 lawyers throughout offices in New York City; Morristown, Princeton, and Ocean City, New Jersey; Westborough, Massachusetts; Wilmington, Delaware; and San Juan, Puerto Rico, the firm is committed to serving clients, providing high-quality work and achieving results. Porzio provides a broad array of litigation, corporate, transactional and counseling services to clients ranging from Fortune 500 corporations to individuals to public entities. For additional information, please visit www.pbnlaw.com.

About Porzio Life Sciences, LLC

Porzio Life Sciences, LLC provides comprehensive commercialization and compliance solutions for Life Sciences companies at all stages of growth and development.  A pioneer in the industry, Porzio Life Sciences offers services and software products that combine the law, compliance, and life sciences business operations.  Porzio Life Sciences' modular approach works to minimize risks and maximize efficiency for in-house compliance, legal and regulatory teams related to global, federal, and state marketing and sales regulations, transparency reporting, supply chain licensing, and third party HCP engagement.